Literature DB >> 12625579

Antimicrobial peptide LL-37 is upregulated in chronic nasal inflammatory disease.

Seon Tae Kim1, Heung Eog Cha, Dong Young Kim, Gyu Cheol Han, Yoo-Sam Chung, Young Jae Lee, You Jin Hwang, Heung-Man Lee.   

Abstract

OBJECTIVE: LL-37 is one of the antimicrobial peptides and the only member of the cathelicidin family identified so far in humans. We attempted to find a correlation between LL-37 peptide and inflammation of the nasal mucosa.
MATERIAL AND METHODS: Nasal mucosa specimens were obtained from 15 chronic infective rhinitis patients and 6 normal controls. Immunohistochemical staining was used to examine the localization of LL-37 and reverse transcriptase polymerase chain reaction (RT-PCR) was used to determine the levels of LL-37, IL-1beta and IL-8 in tissue.
RESULTS: LL-37 peptide was primarily localized in the surface of the epithelia, in the serous and mucous cells of the submucosal glands and in stromal inflammatory cells. The number of LL-37 immunoreactive cells in inflammatory nasal mucosa was significantly increased compared with normal nasal tissue. Using RT-PCR, LL-37 mRNA was detected in 3/6 normal turbinate samples but in all cases with inflammatory nasal tissues. IL-1beta and IL-8 transcripts exhibited a similar pattern to that of LL-37.
CONCLUSIONS: We suggest that LL-37 is one of the antimicrobial peptides found in human nasal mucosa and that it participates in the innate immune system of the nasal mucosa.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12625579     DOI: 10.1080/0036554021000028089

Source DB:  PubMed          Journal:  Acta Otolaryngol        ISSN: 0001-6489            Impact factor:   1.494


  16 in total

1.  A member of the cathelicidin family of antimicrobial peptides is produced in the upper airway of the chinchilla and its mRNA expression is altered by common viral and bacterial co-pathogens of otitis media.

Authors:  Glen McGillivary; William C Ray; Charles L Bevins; Robert S Munson; Lauren O Bakaletz
Journal:  Mol Immunol       Date:  2006-11-20       Impact factor: 4.407

2.  Antimicrobial lipids: novel innate defense molecules are elevated in sinus secretions of patients with chronic rhinosinusitis.

Authors:  Jivianne T Lee; Mike Jansen; Abebayehu N Yilma; Angels Nguyen; Robert Desharnais; Edith Porter
Journal:  Am J Rhinol Allergy       Date:  2010 Mar-Apr       Impact factor: 2.467

Review 3.  Cathelicidins in inflammation and tissue repair: Potential therapeutic applications for gastrointestinal disorders.

Authors:  William Ka Kei Wu; Clover Ching Man Wong; Zhi Jie Li; Lin Zhang; Shun Xiang Ren; Chi Hin Cho
Journal:  Acta Pharmacol Sin       Date:  2010-08-02       Impact factor: 6.150

Review 4.  Modulation of toll-like receptor signaling by antimicrobial peptides.

Authors:  Ernest Y Lee; Michelle W Lee; Gerard C L Wong
Journal:  Semin Cell Dev Biol       Date:  2018-02-12       Impact factor: 7.727

5.  Host defence peptide LL-37 induces IL-6 expression in human bronchial epithelial cells by activation of the NF-kappaB signaling pathway.

Authors:  Jelena Pistolic; Celine Cosseau; Yuexin Li; Jie Jessie Yu; Niall C J Filewod; Shaan Gellatly; Linda M Rehaume; Dawn M E Bowdish; Robert E W Hancock
Journal:  J Innate Immun       Date:  2008-11-06       Impact factor: 7.349

Review 6.  Perspectives on the etiology of chronic rhinosinusitis.

Authors:  Bruce K Tan; Robert P Schleimer; Robert C Kern
Journal:  Curr Opin Otolaryngol Head Neck Surg       Date:  2010-02       Impact factor: 2.064

Review 7.  Chronic rhinosinusitis pathogenesis.

Authors:  Whitney W Stevens; Robert J Lee; Robert P Schleimer; Noam A Cohen
Journal:  J Allergy Clin Immunol       Date:  2015-12       Impact factor: 10.793

8.  Could vitamin d have a potential anti-inflammatory and anti-infective role in bronchiectasis?

Authors:  Jim Bartley; Jeff Garrett; Cameron C Grant; Carlos A Camargo
Journal:  Curr Infect Dis Rep       Date:  2013-04       Impact factor: 3.725

Review 9.  The porcine lung as a potential model for cystic fibrosis.

Authors:  Christopher S Rogers; William M Abraham; Kim A Brogden; John F Engelhardt; John T Fisher; Paul B McCray; Geoffrey McLennan; David K Meyerholz; Eman Namati; Lynda S Ostedgaard; Randall S Prather; Juan R Sabater; David Anthony Stoltz; Joseph Zabner; Michael J Welsh
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2008-05-16       Impact factor: 5.464

10.  Self-RNA-antimicrobial peptide complexes activate human dendritic cells through TLR7 and TLR8.

Authors:  Dipyaman Ganguly; Georgios Chamilos; Roberto Lande; Josh Gregorio; Stephan Meller; Valeria Facchinetti; Bernhard Homey; Franck J Barrat; Tomasz Zal; Michel Gilliet
Journal:  J Exp Med       Date:  2009-08-24       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.